Tag: Luciana Berger

The below Parliamentary question was asked by Luciana Berger on 2014-06-12.

To ask the Secretary of State for Health, how many financial bonuses of what amount have been paid to employees of Public Health England since April 2013; and on what criteria such bonuses were awarded.

Jane Ellison

Financial bonuses have been paid to 20 employees of Public Health England since its establishment on 1 April 2013, all of which relate to their performance in predecessor organisations in the 2012-13 reporting year. The criteria used for the performance assessment and subsequent payments for which they were eligible were those of their former employer.

Of these, 18 were to former employees of the Department of Health, all of which were non-consolidated. The number of payments and amounts were as follows:

Number of payments	Amount (£)
1	210
1	250
1	380
1	480
1	630
1	750
1	825
4	900
1	1,000
4	1,200
1	10,000
1	12,500

The remaining two were to former employees of the Health Protection Agency, which were also non-consolidated, and amounted to £10,000 each.

The below Parliamentary question was asked by Luciana Berger on 2014-06-18.

To ask the Secretary of State for Health, how many NHS-funded cosmetic surgeries have been performed in each of the last four years; and what estimate he has made of the (a) number and (b) proportion of those surgeries which were not based on a mental health need.

Dr Daniel Poulter

This information is not available in the format requested.

The below Parliamentary question was asked by Luciana Berger on 2014-05-07.

To ask the Deputy Prime Minister, what steps the Government is taking to raise the number of people registered to vote.

Greg Clark

The Government is introducing online registration as of 10^th June in England and Wales which will make it more convenient to register to vote.

In addition, five national organisations and every Electoral Registration Officer in Great Britain are sharing £4.2 million funding aimed at maximising the rate of voter registration, as part of the transition to Individual Electoral Registration. These organisations have received funding to find new ways of reaching a range of under registered groups such as young people and encouraging them to register to vote.

The below Parliamentary question was asked by Luciana Berger on 2014-06-12.

To ask the Secretary of State for Health, what assessment he has made of the prevalence and effect of unlicensed performance enhancing drugs (a) online and (b) in shops.

Norman Lamb

There are strict legal controls governing the sale and supply of medicinal products in the United Kingdom.

Unlicensed medicines which claim to enhance performance generally claim to enhance either sexual, cognitive or athletic performance.

The Medicines and Healthcare products Regulatory Agency (MHRA) works with domain name providers to shut down websites which are illegally trading in unlicensed erectile dysfunction medicines and which refuse to come in to compliance.

A UK registered pharmacy may have a presence on the internet; however the requirements of legislation apply equally to both UK internet pharmacies and bricks-and-mortar premises. These legal controls also apply equally to medicines for human use sold or supplied via the internet or e-mail transactions. These restrictions do not apply to countries outside UK jurisdiction where medicines may be classified and regulated differently.

Medicines most commonly associated with enhanced athletic performance are anabolic steroids and human growth hormones. These medicines are controlled as class C drugs under the Misuse of Drugs Act 1971.

The MHRA has serious concerns about the availability of medicines being offered via the Internet and issues regular warnings to the public concerning the inherent risks of purchasing medicines online. MHRA advice is that medicines purchased from websites, particularly websites based overseas, cannot be guaranteed to meet set standards of quality, safety and efficacy and advises patients not to purchase medicines in this way.

The below Parliamentary question was asked by Luciana Berger on 2014-06-18.

To ask the Secretary of State for Health, pursuant to the Answer of 16 June 2014, Official Report, column 486W, on health: business, what assessment his Department makes of the annual updates; and what estimate he has made of the number of hours of officials’ time spent assessing those updates.

Jane Ellison

Officials review annual updates to Responsibility Deal pledges on receipt and liaise with partners directly if any clarification is required.

The Department does not record separately the spent on reviewing annual updates to the Responsibility Deal.

The below Parliamentary question was asked by Luciana Berger on 2014-06-12.

To ask the Secretary of State for Health, pursuant to the Answer of 10 June 2014, Official Report, column 101W, on the human papillomavirus, when the Joint Committee on Vaccination and Immunisation will publish its conclusions into whether the human papillomavirus should be offered to males.

Jane Ellison

The Joint Committee on Vaccination and Immunisation (JCVI) human papillomavirus (HPV) sub-committee will report its findings to the JCVI following consideration of on-going studies by Public Health England on the impact and cost-effectiveness of extending HPV vaccination to men who have sex with men (MSM) and/or adolescent boys.

It is expected that the MSM modelling study will be completed at the end of 2014 at the earliest, and the adolescent boys modelling study will be completed at the end of 2015 at the earliest. The JCVI will then consider the findings of the HPV subcommittee before deciding what advice or recommendations can be made.